Lost opportunities for mismatch repair (MMR) screening among minority women with endometrial cancer

Abstract Lynch Syndrome (LS) prevalence in underrepresented minorities are lacking. The objective of this study was to assess the prevalence of LS in a minority patient population. Secondary objectives included identifying factors associated with successful LS screening and to characterize clinicopa...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Marilyn Huang, Tegan Hunter, Lydia A. Fein, Johnny Galli, Sophia George, Matthew Schlumbrecht, Kelly McCarter, Abdulrahman K. Sinno, Luiz P. Guido, Andre Pinto
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2021
Materias:
R
Q
Acceso en línea:https://doaj.org/article/df98792444ad43febbe22fbdae5500e4
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:df98792444ad43febbe22fbdae5500e4
record_format dspace
spelling oai:doaj.org-article:df98792444ad43febbe22fbdae5500e42021-12-02T18:24:55ZLost opportunities for mismatch repair (MMR) screening among minority women with endometrial cancer10.1038/s41598-021-91053-12045-2322https://doaj.org/article/df98792444ad43febbe22fbdae5500e42021-06-01T00:00:00Zhttps://doi.org/10.1038/s41598-021-91053-1https://doaj.org/toc/2045-2322Abstract Lynch Syndrome (LS) prevalence in underrepresented minorities are lacking. The objective of this study was to assess the prevalence of LS in a minority patient population. Secondary objectives included identifying factors associated with successful LS screening and to characterize clinicopathologic features. Women with endometrial cancer treated within a university system from 2014 and 2016 were included. Immunohistochemistry (IHC) results of MLH1, PMS2, MSH2 and MSH6 were obtained from medical records and clinicopathologic factors abstracted. Patients not previously screened for LS were screened. 276 patients were evaluable. More minority women were screened as part of their routine cancer care (p = 0.005). Additionally, women 50 years or younger were more likely to be screened for LS compared to women older than 51(p = 0.009) and uninsured or reliant on Medicaid patients (p = 0.011) were more likely to be screened during routine care. Six patients received confirmatory germline testing for LS (4.3%), and another 8 patients had a staining pattern suggestive of LS. In an underrepresented population, the rate of LS in endometrial cancer is similar to previous reports. LS may be under diagnosed and opportunities missed when universal screening is not applied in minority women.Marilyn HuangTegan HunterLydia A. FeinJohnny GalliSophia GeorgeMatthew SchlumbrechtKelly McCarterAbdulrahman K. SinnoLuiz P. GuidoAndre PintoNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 11, Iss 1, Pp 1-9 (2021)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Marilyn Huang
Tegan Hunter
Lydia A. Fein
Johnny Galli
Sophia George
Matthew Schlumbrecht
Kelly McCarter
Abdulrahman K. Sinno
Luiz P. Guido
Andre Pinto
Lost opportunities for mismatch repair (MMR) screening among minority women with endometrial cancer
description Abstract Lynch Syndrome (LS) prevalence in underrepresented minorities are lacking. The objective of this study was to assess the prevalence of LS in a minority patient population. Secondary objectives included identifying factors associated with successful LS screening and to characterize clinicopathologic features. Women with endometrial cancer treated within a university system from 2014 and 2016 were included. Immunohistochemistry (IHC) results of MLH1, PMS2, MSH2 and MSH6 were obtained from medical records and clinicopathologic factors abstracted. Patients not previously screened for LS were screened. 276 patients were evaluable. More minority women were screened as part of their routine cancer care (p = 0.005). Additionally, women 50 years or younger were more likely to be screened for LS compared to women older than 51(p = 0.009) and uninsured or reliant on Medicaid patients (p = 0.011) were more likely to be screened during routine care. Six patients received confirmatory germline testing for LS (4.3%), and another 8 patients had a staining pattern suggestive of LS. In an underrepresented population, the rate of LS in endometrial cancer is similar to previous reports. LS may be under diagnosed and opportunities missed when universal screening is not applied in minority women.
format article
author Marilyn Huang
Tegan Hunter
Lydia A. Fein
Johnny Galli
Sophia George
Matthew Schlumbrecht
Kelly McCarter
Abdulrahman K. Sinno
Luiz P. Guido
Andre Pinto
author_facet Marilyn Huang
Tegan Hunter
Lydia A. Fein
Johnny Galli
Sophia George
Matthew Schlumbrecht
Kelly McCarter
Abdulrahman K. Sinno
Luiz P. Guido
Andre Pinto
author_sort Marilyn Huang
title Lost opportunities for mismatch repair (MMR) screening among minority women with endometrial cancer
title_short Lost opportunities for mismatch repair (MMR) screening among minority women with endometrial cancer
title_full Lost opportunities for mismatch repair (MMR) screening among minority women with endometrial cancer
title_fullStr Lost opportunities for mismatch repair (MMR) screening among minority women with endometrial cancer
title_full_unstemmed Lost opportunities for mismatch repair (MMR) screening among minority women with endometrial cancer
title_sort lost opportunities for mismatch repair (mmr) screening among minority women with endometrial cancer
publisher Nature Portfolio
publishDate 2021
url https://doaj.org/article/df98792444ad43febbe22fbdae5500e4
work_keys_str_mv AT marilynhuang lostopportunitiesformismatchrepairmmrscreeningamongminoritywomenwithendometrialcancer
AT teganhunter lostopportunitiesformismatchrepairmmrscreeningamongminoritywomenwithendometrialcancer
AT lydiaafein lostopportunitiesformismatchrepairmmrscreeningamongminoritywomenwithendometrialcancer
AT johnnygalli lostopportunitiesformismatchrepairmmrscreeningamongminoritywomenwithendometrialcancer
AT sophiageorge lostopportunitiesformismatchrepairmmrscreeningamongminoritywomenwithendometrialcancer
AT matthewschlumbrecht lostopportunitiesformismatchrepairmmrscreeningamongminoritywomenwithendometrialcancer
AT kellymccarter lostopportunitiesformismatchrepairmmrscreeningamongminoritywomenwithendometrialcancer
AT abdulrahmanksinno lostopportunitiesformismatchrepairmmrscreeningamongminoritywomenwithendometrialcancer
AT luizpguido lostopportunitiesformismatchrepairmmrscreeningamongminoritywomenwithendometrialcancer
AT andrepinto lostopportunitiesformismatchrepairmmrscreeningamongminoritywomenwithendometrialcancer
_version_ 1718378130377277440